AI and blood tests aim to predict brain damage before it happens
NCT ID NCT06069973
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether machine learning and special brain injury markers in blood and spinal fluid can warn doctors early when a patient with a brain bleed is developing delayed cerebral ischemia (lack of oxygen to the brain). Researchers will monitor 1,500 adults in intensive care using heart rate, brain waves, and oxygen sensors. The goal is to build an early warning system that could help prevent lasting brain injury.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could create an early warning system to detect brain oxygen deprivation sooner, potentially reducing brain damage and improving recovery after bleeding in the brain.
What could go wrong
This is an observational study, not a treatment trial. The machine learning model may not be accurate enough in real-world settings, and the results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sahlgrenska University Hospital
RECRUITINGGothenburg, 41345, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••